Lipid Management in Patients with Diabetes

Join Mayo Clinic Cardiologists R. Scott Wright, M.D.  and Mandeep Singh, M.D. to review the newer treatment options available for cardiovascular and primary care providers for appropriate risk reduction in Type 2 DM patients. Review the newer, lower LDL-C Thresholds expected for primary and secondary prevention for Type 2 DM patients. 

TOPICS INCLUDE:

• Review the new recommended LDL-C thresholds for patients with Type 2 DM.
• Review newer therapies including oral and PCSK 9 directed therapies.
• Review the safety and efficacy data with Inclisiran and bempedoic acid.
• Review strategies to lower LDL-C in type 2 DM patients.

Length: 00:50:05